ClinicalTrials.govpublic full text
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
breast neoplasms, breast cancer, cancer of the breast, metastatic breast cancer, triple negative breast cancer, estrogen receptor (er)/progesterone receptor (pr)/human epidermal growth factor receptor 2 (her2)-negative breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 875166
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.